UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000025057 |
|---|---|
| Receipt number | R000028835 |
| Scientific Title | An observational study evaluating prevalence of frailty in patients with urological disease (FRAURO study) |
| Date of disclosure of the study information | 2017/01/31 |
| Last modified on | 2022/12/05 22:15:33 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/11/29 22:17:37 | ||
| 2 | Update | 2017/03/22 10:53:13 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2017/08/03 21:53:05 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 4 | Update | 2019/04/08 23:34:20 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 5 | Update | 2019/04/10 22:52:21 | Primary outcomes Primary outcomes |
|
| 6 | Update | 2019/04/13 08:18:32 | Primary outcomes Primary outcomes |
|
| 7 | Update | 2019/04/13 09:24:34 | Primary outcomes Primary outcomes |
|
| 8 | Update | 2019/04/13 09:44:35 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 9 | Update | 2019/06/16 09:03:12 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 10 | Update | 2020/03/18 12:42:48 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Email3 Organization Organization Address Address Tel |
|
| 11 | Update | 2020/03/18 12:45:00 | Date of IRB Anticipated trial start date Last follow-up date Other related information Other related information |
|
| 12 | Update | 2020/03/18 13:03:00 | Key secondary outcomes Key secondary outcomes |
|
| 13 | Update | 2020/03/18 13:04:26 | Other related information Other related information |
|
| 14 | Update | 2020/03/18 13:04:56 | Key secondary outcomes Key secondary outcomes |
|
| 15 | Update | 2020/03/18 13:21:12 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 16 | Update | 2020/03/18 13:21:48 | Other related information Other related information |
|
| 17 | Update | 2020/03/18 13:40:12 | Key secondary outcomes Key secondary outcomes |
|
| 18 | Update | 2020/03/18 13:55:50 | Key secondary outcomes Key secondary outcomes |
|
| 19 | Update | 2020/03/18 13:57:36 | Public title Acronym Scientific Title Scientific Title:Acronym |
|
| 20 | Update | 2020/03/18 23:53:13 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 21 | Update | 2020/03/18 23:54:27 | Other related information Other related information |
|
| 22 | Update | 2020/03/19 13:45:36 | Other related information Other related information |
|
| 23 | Update | 2020/03/19 13:46:28 | Key secondary outcomes Key secondary outcomes |
|
| 24 | Update | 2020/03/19 13:46:51 | Other related information Other related information |
|
| 25 | Update | 2020/03/19 14:33:18 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 26 | Update | 2020/03/19 14:34:15 | Public title Public title Acronym Acronym Scientific Title Scientific Title Scientific Title:Acronym Scientific Title:Acronym |
|
| 27 | Update | 2020/03/19 14:37:39 | Other related information Other related information |
|
| 28 | Update | 2020/04/15 21:18:05 | Other related information Other related information |
|
| 29 | Update | 2021/06/23 08:23:14 | Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 30 | Update | 2021/06/23 08:26:39 | Results Results Results date posted Baseline Characteristics Baseline Characteristics |
|
| 31 | Update | 2021/06/23 08:36:07 | Other related information Other related information |
|
| 32 | Update | 2021/06/23 08:54:06 | Primary outcomes Primary outcomes |
|
| 33 | Update | 2021/06/23 10:00:01 | Narrative objectives1 Narrative objectives1 Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 34 | Update | 2021/06/23 10:02:51 | Results Results |
|
| 35 | Update | 2021/06/23 12:40:56 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 36 | Update | 2021/06/23 12:47:42 | Primary outcomes Primary outcomes Key secondary outcomes Key secondary outcomes |
|
| 37 | Update | 2021/06/23 12:48:46 | Other related information Other related information |
|
| 38 | Update | 2021/06/24 17:13:03 | Recruitment status |
|
| 39 | Update | 2021/06/24 17:13:33 | Number of participants that the trial has enrolled |
|
| 40 | Update | 2021/07/07 09:14:26 | Other related information Other related information |
|
| 41 | Update | 2021/07/07 09:15:38 | Anticipated trial start date |
|
| 42 | Update | 2022/12/05 22:13:51 | Recruitment status Date of IRB |
|
| 43 | Update | 2022/12/05 22:14:18 | Last follow-up date |
|
| 44 | Update | 2022/12/05 22:14:58 | Publication of results |
|
| 45 | Update | 2022/12/05 22:15:35 | Other related information Other related information |
